CAPPED BONUSZERTIFIKAT - STRYKER CORP. Stock

Certificat

DE000PC5RT28

Real-time Boerse Frankfurt Warrants 10:20:59 2024-05-23 am EDT
249.4 EUR -0.11% Intraday chart for CAPPED BONUSZERTIFIKAT - STRYKER CORP.
Current month-0.49%
1 month-0.24%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-23 249.4 -0.11%
24-05-22 249.7 +0.43%
24-05-21 248.6 +0.10%
24-05-20 248.4 +0.13%
24-05-17 248 -0.03%

Real-time Boerse Frankfurt Warrants

Last update May 23, 2024 at 10:20 am EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5RT2
ISINDE000PC5RT28
Date issued 2024-02-27
Strike 280 $
Maturity 2024-12-20 (211 Days)
Parity 1 : 1
Emission price 244
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 251.4
Lowest since issue 242.3
Spread 1
Spread %0.40%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.4 USD
Average target price
372.4 USD
Spread / Average Target
+11.01%
Consensus